Live from the NIH registry
Studies recruiting near Salt Lake City right now
Top 25 of 1,165 recruiting studies, sorted by proximity — each links to its official registry page
One-Time DNA Study for Vasculitis
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Giant Cell Arteritis
N/A
Observational 1,000 participants sought
University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: University of Pennsylvania
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Utah Cancer Specialists-Salt Lake City — Salt Lake City, Utah (2.4 mi)
· Sponsor: SWOG Cancer Research Network
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Primary Children's Hospital — Salt Lake City, Utah (2.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Intermountain Medical Center ( Site 0182) — Murray, Utah (8.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Salt Lake City, Utah (2.4 mi)
· Sponsor: Sameek Roychowdhury
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 2
Interventional 224 participants sought
University of Utah Hospitals & Clinics — Salt Lake City, Utah (2.4 mi)
· Sponsor: Genentech, Inc.
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Huntsman Cancer Institute, University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: Relay Therapeutics, Inc.
Massage: Neuroimaging and Correlates of Response - 6-week Study
Healthy Control
N/A
Interventional 46 participants sought
Huntsman Mental Health Institute — Salt Lake City, Utah (2.4 mi)
· Sponsor: University of Utah
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection Recurrence
Phase 2
Interventional 20 participants sought
University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: Acurx Pharmaceuticals Inc.
NETs: Protection or Harm in Neonatal Inflammation or Infection
Necrotizing Enterocolitis (NEC)
N/A
Observational 388 participants sought
University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: University of Utah
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Utah Cancer Specialists-Salt Lake City — Salt Lake City, Utah (2.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Retina Associates of Utah, PLLC — Salt Lake City, Utah (2.4 mi)
· Sponsor: Genentech, Inc.
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma
Phase 1
Interventional 694 participants sought
Start Mountain Region /ID# 276270 — West Valley City, Utah (7.0 mi)
· Sponsor: AbbVie
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10305, Layton, UT — Layton, Utah (19.6 mi)
· Sponsor: Colorado Prevention Center
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Highland Clinical Research /ID# 270281 — Salt Lake City, Utah (2.4 mi)
· Sponsor: AbbVie
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Transthyretin Amyloidosis With Cardiomyopathy
Phase 3
Interventional 1,750 participants sought
Clinical Trial Site — Salt Lake City, Utah (2.4 mi)
· Sponsor: Alnylam Pharmaceuticals
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric)
Phase 3
Interventional 117 participants sought
Eccles Primary Children's Outpatient Services - Cardiology — Salt Lake City, Utah (2.4 mi)
· Sponsor: Bayer
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
Phase 2
Interventional 113 participants sought
Adult Cystic Fibrosis Center at the University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: Anagram Therapeutics, Inc.
Precision Genomics Medicine Biobank
Any Disease Condition and Reportedly-healthy Subjects
N/A
Observational 100,000 participants sought
Intermountain Healthcare — Murray, Utah (8.0 mi)
· Sponsor: Intermountain Health Care, Inc.
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Medulloblastoma
Phase 2
Interventional 130 participants sought
Primary Children's Hospital — Salt Lake City, Utah (2.4 mi)
· Sponsor: St. Jude Children's Research Hospital
Effect of Sleep Extension on Ceramides in People with Overweight and Obesity
Lifestyle Factors, Overweight and Obesity
N/A
Interventional 70 participants sought
College of Health Research Complex--University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: University of Utah
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Large B-cell Lymphoma
Phase 2
Interventional 250 participants sought
Huntsman Cancer Institute, University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: Allogene Therapeutics
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer
Phase 3
Interventional 590 participants sought
Utah Cancer Specialists — Salt Lake City, Utah (2.4 mi)
· Sponsor: Revolution Medicines, Inc.
A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.
Chikungunya Virus
Phase 3
Interventional 720 participants sought
Velocity Clinical Research - Salt Lake City — West Jordan, Utah (11.6 mi)
· Sponsor: Bavarian Nordic
Shortened Course of Radiation Therapy After Trans-oral Robotic Surgery in Patients With HPV-Mediated Oropharyngeal Squamous Cell Carcinoma.
Oropharyngeal Squamous Cell Carcinoma, HPV-mediated Oropharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 42 participants sought
Huntsman Cancer Institute/University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: University of Utah